Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma
Payal D. Shah(Rutgers, The State University of New Jersey), Tara C. Mitchell(Hospital of the University of Pennsylvania)
Cited by 90
Related Papers
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
|Journal of Clinical Oncology|2018|382
Shared and distinct biological circuits in effector, memory and exhausted CD8+ T cells revealed by temporal single-cell transcriptomics and epigenetics
|Nature Immunology|2022|255
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers
|Immunity|2022|122
Breast Cancer<sup>18</sup>F-ISO-1 Uptake as a Marker of Proliferation Status
|Journal of Nuclear Medicine|2019|38